News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
KASINGER JAMES R.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/14/2023 |
4
| KASINGER JAMES R. (General Counsel and Secretary) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Paid exercise price by delivering 1,283 shares
@ $43.22, valued at
$55.5k
Paid exercise price by delivering 1,022 shares
@ $43.22, valued at
$44.2k
Exercised 2,833 restricted stock units
@ $0
Granted 40,000 options to buy
@ $43.22, valued at
$1.7M
Granted 22,000 restricted stock units
@ $0
Exercised 2,250 restricted stock units
@ $0 |
|
| 02/22/2023 |
4
| KASINGER JAMES R. (General Counsel and Secretary) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Paid exercise price by delivering 1,950 shares
@ $48.26, valued at
$94.1k
Exercised 3,825 restricted stock units
@ $0 |
|
| 12/06/2022 |
4
| KASINGER JAMES R. (General Counsel and Secretary) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Paid exercise price by delivering 3,234 shares
@ $52.26, valued at
$169k
Exercised 6,667 restricted stock units
@ $0 |
|
| 10/12/2022 |
4
| KASINGER JAMES R. (General Counsel and Secretary) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 14,000 options to buy
@ $61.65, valued at
$863.1k
|
|
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2021 |
4
| KASINGER JAMES R. (General Counsel and Secretary) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 10,800 options to buy
@ $97, valued at
$1M
|
|
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2020 |
4
| KASINGER JAMES R. (General Counsel and Secretary) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Exercised 22,026 options to buy
@ $13.62, valued at
$300k
|
|
| 10/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2019 |
4
| KASINGER JAMES R. (General Counsel and Secretary) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 20,000 restricted stock units
@ $0 |
|
| 09/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2019 |
4
| KASINGER JAMES R. (General Counsel and Secretary) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 65,000 options to buy
@ $40.87, valued at
$2.7M
|
|
| 06/15/2018 |
4
| KASINGER JAMES R. (General Counsel and Secretary) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 32,000 options to buy
@ $59.31, valued at
$1.9M
|
|
| 03/09/2018 |
4
| KASINGER JAMES R. (General Counsel and Secretary) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 40,000 options to buy
@ $51.49, valued at
$2.1M
|
|
| 06/02/2017 |
4
| KASINGER JAMES R. (General Counsel and Secretary) has filed a Form 4 on CRISPR Therapeutics AG|
Txns:
| Granted 123,000 options to buy
@ $13.62, valued at
$1.7M
|
|
| 06/01/2017 |
3
| KASINGER JAMES R. (General Counsel and Secretary) has filed a Form 3 on CRISPR Therapeutics AG |
|
|